|
1
|
Urbano FL: Review of the NAEPP 2007 Expert
Panel Report (EPR-3) on Asthma Diagnosis and Treatment Guidelines.
J Manag Care Pharm. 14:41–49. 2008.PubMed/NCBI
|
|
2
|
Centers for Disease Control and Prevention
(CDC): Vital signs: asthma prevalence, disease characteristics, and
self-management education: United States, 2001 - 2009. MMWR Morb
Mortal Wkly Rep. 60:547–552. 2011.PubMed/NCBI
|
|
3
|
Croisant S: Epidemiology of asthma:
prevalence and burden of disease. Adv Exp Med Biol. 795:17–29.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Akinbami LJ, Moorman JE, Bailey C, Zahran
HS, King M, Johnson CA and Liu X: Trends in asthma prevalence,
health care use, and mortality in the United States, 2001–2010.
NCHS Data Brief. 1–8. 2012.PubMed/NCBI
|
|
5
|
Holgate ST: A look at the pathogenesis of
asthma: the need for a change in direction. Discov Med. 9:439–447.
2010.PubMed/NCBI
|
|
6
|
Corren J, Lemanske RF Jr, Hanania NA,
Korenblat PE, Parsey MV, Arron JR, Harris JM, Scheerens H, Wu LC,
Su Z, et al: Lebrikizumab treatment in adults with asthma. N Engl J
Med. 365:1088–1098. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hafkamp-de Groen E, Mohangoo AD, de
Jongste JC, van der Wouden JC, Moll HA, Jaddoe VW, Hofman A, de
Koning HJ and Raat H: Early detection and counselling intervention
of asthma symptoms in preschool children: study design of a cluster
randomised controlled trial. BMC Public Health. 10:5552010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
National Asthma Education and Prevention
Program: Expert Panel Report 3 (EPR-3): Guidelines for the
Diagnosis and Management of Asthma-Summary Report 2007. J Allergy
Clin Immunol. 120:(Suppl 5). S94–S138. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cave AJ and Atkinson LL: Asthma in
preschool children: a review of the diagnostic challenges. J Am
Board Fam Med. 27:538–548. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Busse WW: Asthma diagnosis and treatment:
filling in the information gaps. J Allergy Clin Immunol.
128:740–750. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dahlén SE, Dahlén B and Drazen JM: Asthma
treatment guidelines meet the real world. N Engl J Med.
364:1769–1770. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Locksley RM: Asthma and allergic
inflammation. Cell. 140:777–783. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Busse WW: The relationship of airway
hyperresponsiveness and airway inflammation: Airway
hyperresponsiveness in asthma: its measurement and clinical
significance. Chest. 138:(Suppl 2). 4S–10S. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bébéar C, Pereyre S and Peuchant O:
Mycoplasma pneumoniae: susceptibility and resistance to
antibiotics. Future Microbiol. 6:423–431. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Khan FY and Sayed H: Rhabdomyolysis
associated with Mycoplasma pneumoniae pneumonia. Hong Kong
Med J. 18:247–249. 2012.PubMed/NCBI
|
|
16
|
van der Poll T and Opal SM: Pathogenesis,
treatment, and prevention of pneumococcal pneumonia. Lancet.
374:1543–1556. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Waites KB, Balish MF and Atkinson TP: New
insights into the pathogenesis and detection of Mycoplasma
pneumoniae infections. Future Microbiol. 3:635–648. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Narita M: Pathogenesis of extrapulmonary
manifestations of Mycoplasma pneumoniae infection with
special reference to pneumonia. J Infect Chemother. 16:162–169.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hong SJ: The role of Mycoplasma
pneumoniae infection in asthma. Allergy Asthma Immunol Res.
4:59–61. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Watanabe H, Uruma T, Nakamura H and
Aoshiba K: The role of Mycoplasma pneumoniae infection in
the initial onset and exacerbations of asthma. Allergy Asthma Proc.
35:204–210. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang M, Wang Y, Yan Y, Zhu C, Huang L,
Shao X, Xu J, Zhu H, Sun X, Ji W, et al: Clinical and laboratory
profiles of refractory Mycoplasma pneumoniae pneumonia in
children. Int J Infect Dis. 29:18–23. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wenzel S, Ford L, Pearlman D, Spector S,
Sher L, Skobieranda F, Wang L, Kirkesseli S, Rocklin R, Bock B, et
al: Dupilumab in persistent asthma with elevated eosinophil levels.
N Engl J Med. 368:2455–2466. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schleich FN, Seidel L, Sele J, Manise M,
Quaedvlieg V, Michils A and Louis R: Exhaled nitric oxide
thresholds associated with a sputum eosinophil count ≥3% in a
cohort of unselected patients with asthma. Thorax. 65:1039–1044.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Atkinson TP and Waites KB: Mycoplasma
pneumoniae infections in childhood. Pediatr Infect Dis J.
33:92–94. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wood PR, Hill VL, Burks ML, Peters JI,
Singh H, Kannan TR, Vale S, Cagle MP, Principe MF, Baseman JB, et
al: Mycoplasma pneumoniae in children with acute and
refractory asthma. Ann Allergy Asthma Immunol. 110:328–334. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Holt GR: Declaration of Helsinki - the
world's document of conscience and responsibility. South Med J.
107:4072014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Subspecialty Group of Respiratory Diseases
Society of Pediatrics; Chinese Medical Association; Chinese Journal
of Pediatrics Editorial Board: Guideline for the diagnosis and
optimal management of asthma in children. Zhonghua Er Ke Za Zhi.
46:745–753. 2008.(In Chinese). PubMed/NCBI
|
|
28
|
Zhang YM and Liu XY: Advance in the
diagnosis and treatment of Mycoplasma pneumoniae pneumonia
and related complications. Zhongguo Dang Dai Er Ke Za Zhi.
13:358–360. 2011.(In Chinese). PubMed/NCBI
|
|
29
|
Chen H, Manning AK and Dupuis J: A method
of moments estimator for random effect multivariate meta-analysis.
Biometrics. 68:1278–1284. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jackson D, White IR and Riley RD:
Quantifying the impact of between-study heterogeneity in
multivariate meta-analyses. Stat Med. 31:3805–3820. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Peters JL, Sutton AJ, Jones DR, Abrams KR
and Rushton L: Comparison of two methods to detect publication bias
in meta-analysis. JAMA. 295:676–680. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zintzaras E and Ioannidis JP:
Heterogeneity testing in meta-analysis of genome searches. Genet
Epidemiol. 28:123–137. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Atkinson TP, Duffy LB, Pendley D, Dai Y
and Cassell GH: Deficient immune response to Mycoplasma
pneumoniae in childhood asthma. Allergy Asthma Proc.
30:158–165. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Esposito S, Blasi F, Arosio C, Fioravanti
L, Fagetti L, Droghetti R, Tarsia P, Allegra L and Principi N:
Importance of acute Mycoplasma pneumoniae and Chlamydia
pneumoniae infections in children with wheezing. Eur Respir J.
16:1142–1146. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Smith-Norowitz TA, Silverberg JI,
Kusonruksa M, Weaver D, Ginsburg D, Norowitz KB, Durkin HG,
Hammerschlag MR, Bluth MH and Kohlhoff SA: Asthmatic children have
increased specific anti-Mycoplasma pneumoniae IgM but not
IgG or IgE-values independent of history of respiratory tract
infection. Pediatr Infect Dis J. 32:599–603. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Thumerelle C, Deschildre A, Bouquillon C,
Santos C, Sardet A, Scalbert M, Delbecque L, Debray P, Dewilde A,
Turck D, et al: Role of viruses and atypical bacteria in
exacerbations of asthma in hospitalized children: a prospective
study in the Nord-Pas de Calais region (France). Pediatr Pulmonol.
35:75–82. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Varshney AK, Chaudhry R, Saharan S, Kabra
SK, Dhawan B, Dar L and Malhotra P: Association of Mycoplasma
pneumoniae and asthma among Indian children. FEMS Immunol Med
Microbiol. 56:25–31. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
He ZH, Zhang JT and Sun YF: Correlation
between mycoplasma pnenumonia infection and pediatric asthma. Chin
J Nosocomiol. 21:4733–4734. 2011.(In Chinese).
|
|
39
|
Jiang H: Mycoplasma pneumoniae
infection and bronchial asthma in children. Chin J Med Guide.
15:1275–1276. 2013.(In Chinese).
|
|
40
|
Liu CX: Analysis of the relationship
between bronchial asthma and Mycoplasma pneumoniae
infection. Chin J Postgrad Med. 32:49–50. 2009.(In Chinese).
http://d.g.wanfangdata.com.cn/Periodical_ysjxzz200915022.aspx
|
|
41
|
Zhao ZY: Observation on infection results
and correlation between childhood asthma and Mycoplasma
pneumoniae. J Clin Pulm Med. 8:1497–1498, 1522. 2014.(In
Chinese).
|
|
42
|
Guilbert TW and Denlinger LC: Role of
infection in the development and exacerbation of asthma. Expert Rev
Respir Med. 4:71–83. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Rollins DR, Beuther DA and Martin RJ:
Update on infection and antibiotics in asthma. Curr Allergy Asthma
Rep. 10:67–73. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ke LQ, Wang FM, Li YJ and Luo YC:
Epidemiological characteristics of Mycoplasma pneumoniae
pneumonia in children. Zhongguo Dang Dai Er Ke Za Zhi. 15:33–36.
2013.(In Chinese). PubMed/NCBI
|
|
45
|
Burton OT and Oettgen HC: Beyond immediate
hypersensitivity: evolving roles for IgE antibodies in immune
homeostasis and allergic diseases. Immunol Rev. 242:128–143. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Defilippi A, Silvestri M, Tacchella A,
Giacchino R, Melioli G, Di Marco E, Cirillo C, Di Pietro P and
Rossi GA: Epidemiology and clinical features of Mycoplasma
pneumoniae infection in children. Respir Med. 102:1762–1768.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Green RH, Brightling CE, McKenna S,
Hargadon B, Parker D, Bradding P, Wardlaw AJ and Pavord ID: Asthma
exacerbations and sputum eosinophil counts: a randomised controlled
trial. Lancet. 360:1715–1721. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Fleming L, Wilson N, Regamey N and Bush A:
Use of sputum eosinophil counts to guide management in children
with severe asthma. Thorax. 67:193–198. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Nakagome K and Nagata M: Pathogenesis of
airway inflammation in bronchial asthma. Auris Nasus Larynx.
38:555–563. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
van Rensen EL, Evertse CE, van Schadewijk
WA, van Wijngaarden S, Ayre G, Mauad T, Hiemstra PS, Sterk PJ and
Rabe KF: Eosinophils in bronchial mucosa of asthmatics after
allergen challenge: effect of anti-IgE treatment. Allergy.
64:72–80. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Tantisira KG, Colvin R, Tonascia J, Strunk
RC, Weiss ST and Fuhlbrigge AL: Childhood Asthma Management Program
Research Group: Airway responsiveness in mild to moderate childhood
asthma: sex influences on the natural history. Am J Respir Crit
Care Med. 178:325–331. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Apter AJ: Advances in adult asthma
diagnosis and treatment and HEDQ in 2010. J Allergy Clin Immunol.
127:116–122. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Laviolette M, Gossage DL, Gauvreau G,
Leigh R, Olivenstein R, Katial R, Busse WW, Wenzel S, Wu Y, Datta
V, et al: Effects of benralizumab on airway eosinophils in
asthmatic patients with sputum eosinophilia. J Allergy Clin
Immunol. 132:1086–1096. 2013. View Article : Google Scholar : PubMed/NCBI
|
